Clinical Trial Update: Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating cognitive impairments in chronic hepatitis C patients and whether new agents can reverse them.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: Hepatitis C | Phase 4 | Status: UNKNOWN